Literature DB >> 28832491

Committee Opinion No. 720: Maternal-Fetal Surgery for Myelomeningocele.

.   

Abstract

Myelomeningocele, a severe form of spina bifida, occurs in approximately 1 in 3,000 live births in the United States. The extent of disability is generally related to the level of the myelomeningocele defect, with a higher upper level of lesion generally corresponding to greater deficits. Open maternal-fetal surgery for myelomeningocele repair is a major procedure for the woman and her affected fetus. Although there is demonstrated potential for fetal and pediatric benefit, there are significant maternal implications and complications that may occur acutely, postoperatively, for the duration of the pregnancy, and in subsequent pregnancies. Women with pregnancies complicated by fetal myelomeningocele who meet established criteria for in utero repair should be counseled in a nondirective fashion regarding all management options, including the possibility of open maternal-fetal surgery. Maternal-fetal surgery for myelomeningocele repair should be offered only to carefully selected patients at facilities with an appropriate level of personnel and resources.

Entities:  

Mesh:

Year:  2017        PMID: 28832491     DOI: 10.1097/AOG.0000000000002303

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  3 in total

1.  A study to assess global availability of fetal surgery for myelomeningocele.

Authors:  Adalina Sacco; Lynn Simpson; Jan Deprest; Anna L David
Journal:  Prenat Diagn       Date:  2018-11-20       Impact factor: 3.242

2.  Perinatal outcomes after open fetal surgery for myelomeningocele repair: a retrospective cohort study.

Authors:  A F Moron; M M Barbosa; Hjf Milani; S G Sarmento; Efm Santana; I C Suriano; P A Dastoli; S Cavalheiro
Journal:  BJOG       Date:  2018-07-06       Impact factor: 6.531

Review 3.  Fetal surgery for open spina bifida.

Authors:  Adalina Sacco; Fred Ushakov; Dominic Thompson; Donald Peebles; Pranav Pandya; Paolo De Coppi; Ruwan Wimalasundera; George Attilakos; Anna Louise David; Jan Deprest
Journal:  Obstet Gynaecol       Date:  2019-09-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.